Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
9
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Hosseinion Warren | Director, 10% Owner | 9 | $635.06M | $0 | 2021-02-25 |
| Schimmel Lawrence | Chief Medical Officer | 4 | $2.91B | $0 | 2021-01-28 |
| Breslin Terence Martin | Director, 10% Owner | 4 | $634.92M | $0 | 2021-01-28 |
| Meiri David | Director | 4 | $634.92M | $0 | 2021-01-28 |
| Fawcett Mark | Director | 5 | $24.0K | $0 | 2021-01-28 |
| Creem Mitchell | Director | 4 | $634.92M | $0 | 2021-01-28 |
| Luqman Elisa V | Chief Financial Officer | 5 | $0 | $0 | 2021-01-28 |
| Waters John J | Director | 6 | $634.92M | $0 | 2021-01-28 |
| Margolin Jacob | Director | 3 | $42.45B | $0 | 2020-07-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Hosseinion Warren | Chief Executive Officer | J Other | 2021-02-25 | 2021-12-21 | 894,209 | $2.04 | $1.82M | 1,151,563 | SEC↗ |
| Fawcett Mark | Director | J Other | 2021-01-28 | 2021-12-21 | 268,263 | $2.04 | $547.3K | 277,259 | SEC↗ |
| Luqman Elisa V | Chief Financial Officer | A Award deriv | 2021-01-28 | 2021-02-03 | 400,000 | $1.61 | $644.0K | 517,106 | SEC↗ |
| Creem Mitchell | Director | A Award deriv | 2021-01-28 | 2021-02-03 | 45,000 | $1.61 | $72.5K | 130,120 | SEC↗ |
| Hosseinion Warren | Director, 10% Owner | A Award deriv | 2021-01-28 | 2021-02-03 | 600,000 | $1.61 | $966.0K | 800,000 | SEC↗ |
| Breslin Terence Martin | Director, 10% Owner | A Award deriv | 2021-01-28 | 2021-02-04 | 45,000 | $1.61 | $72.5K | 130,120 | SEC↗ |
| Meiri David | Director | A Award deriv | 2021-01-28 | 2021-02-04 | 45,000 | $1.61 | $72.5K | 130,120 | SEC↗ |
| Waters John J | Director | A Award deriv | 2021-01-28 | 2021-02-05 | 45,000 | $1.61 | $72.5K | 147,800 | SEC↗ |
| Luqman Elisa V | Chief Financial Officer | A Award | 2021-01-28 | 2021-02-03 | 1,500 | $1.61 | $2.4K | 12,870 | SEC↗ |
| Schimmel Lawrence | Chief Executive Officer | A Award | 2021-01-28 | 2021-02-03 | 107,692 | $0.65 | $70.0K | 234,047 | SEC↗ |
| Hosseinion Warren | Director | D To issuer | 2020-08-12 | 2020-09-09 | 31,746 | $20000.00 | $634.92M | 237,521 | SEC↗ |
| Waters John J | Director | P Buy | 2020-08-12 | 2020-09-09 | 31,746 | $20000.00 | $634.92M | 31,746 | SEC↗ |
| Breslin Terence Martin | Director, 10% Owner | P Buy | 2020-08-12 | 2020-09-09 | 31,746 | $20000.00 | $634.92M | 724,496 | SEC↗ |
| Creem Mitchell | Director | P Buy | 2020-08-12 | 2020-09-09 | 31,746 | $20000.00 | $634.92M | 31,746 | SEC↗ |
| Meiri David | Director | P Buy | 2020-08-12 | 2020-09-09 | 31,746 | $20000.00 | $634.92M | 266,627 | SEC↗ |
| Hosseinion Warren | Director | P Buy | 2020-08-12 | 2020-09-09 | 31,746 | $20000.00 | $634.92M | 237,521 | SEC↗ |
| Fawcett Mark | Director | P Buy deriv | 2020-08-05 | 2021-12-21 | 85,120 | — | $0 | 85,120 | SEC↗ |
| Margolin Jacob | Director | P Buy | 2020-07-13 | 2020-09-29 | 228,346 | $179800.00 | $41.06B | 574,998 | SEC↗ |
| Schimmel Lawrence | Chief Executive Officer | P Buy | 2020-06-30 | 2020-09-09 | 44,828 | $65000.00 | $2.91B | 126,355 | SEC↗ |
| Margolin Jacob | Director | P Buy | 2020-06-30 | 2020-09-29 | 31,034 | $45000.00 | $1.40B | 349,652 | SEC↗ |
| Margolin Jacob | Director | A Award deriv | 2020-05-11 | 2020-09-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Luqman Elisa V | Chief Financial Officer | A Award deriv | 2020-05-11 | 2020-06-15 | 50,000 | — | $0 | 117,106 | SEC↗ |
| Fawcett Mark | Director | A Award deriv | 2020-05-11 | 2020-06-16 | 30,000 | — | $0 | 88,718 | SEC↗ |
| Waters John J | Director | A Award deriv | 2020-05-11 | 2020-06-16 | 50,000 | — | $0 | 174,283 | SEC↗ |
| Meiri David | Director | A Award deriv | 2020-05-11 | 2020-06-16 | 30,000 | — | $0 | 85,120 | SEC↗ |
| Hosseinion Warren | Director | A Award deriv | 2020-05-11 | 2020-06-17 | 100,000 | — | $0 | 221,590 | SEC↗ |
| Schimmel Lawrence | Chief Medical Officer | A Award deriv | 2020-05-11 | 2020-06-18 | 30,000 | — | $0 | 45,168 | SEC↗ |
| Creem Mitchell | Director | A Award deriv | 2020-05-11 | 2020-06-18 | 30,000 | — | $0 | 85,120 | SEC↗ |
| Breslin Terence Martin | Director, 10% Owner | A Award deriv | 2020-05-11 | 2020-06-23 | 30,000 | — | $0 | 85,120 | SEC↗ |
| Hosseinion Warren | Chief Executive Officer | P Buy deriv | 2020-01-27 | 2021-12-21 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Luqman Elisa V | Chief Financial Officer | A Award deriv | 2020-01-27 | 2020-04-24 | 61,706 | — | $0 | 61,706 | SEC↗ |
| Luqman Elisa V | Chief Financial Officer | A Award deriv | 2020-01-27 | 2020-04-24 | 5,400 | — | $0 | 5,400 | SEC↗ |
| Meiri David | Director | A Award deriv | 2020-01-27 | 2020-04-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Waters John J | Director | A Award deriv | 2020-01-27 | 2020-04-24 | 7,800 | — | $0 | 7,800 | SEC↗ |
| Waters John J | Director | A Award deriv | 2020-01-27 | 2020-04-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Breslin Terence Martin | Director | A Award deriv | 2020-01-27 | 2020-04-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Schimmel Lawrence | Chief Medical Officer | A Award deriv | 2020-01-27 | 2020-04-24 | 6,288 | — | $0 | 6,288 | SEC↗ |
| Hosseinion Warren | Director | P Buy deriv | 2020-01-27 | 2020-04-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Waters John J | Director | A Award deriv | 2020-01-27 | 2020-04-28 | 45,000 | — | $0 | 119,031 | SEC↗ |
| Creem Mitchell | Director | A Award deriv | 2020-01-27 | 2020-04-28 | 45,000 | — | $0 | 55,120 | SEC↗ |
| Hosseinion Warren | Director | A Award deriv | 2020-01-27 | 2020-04-28 | 100,000 | — | $0 | 121,590 | SEC↗ |
| Fawcett Mark | Director | A Award deriv | 2020-01-27 | 2020-04-29 | 45,000 | — | $0 | 58,718 | SEC↗ |
| Fawcett Mark | Director | P Buy deriv | 2019-03-21 | 2021-12-21 | 3,598 | $6.67 | $24.0K | 3,598 | SEC↗ |
| Hosseinion Warren | Chief Executive Officer | P Buy deriv | 2019-03-19 | 2021-12-21 | 21,590 | $6.67 | $144.0K | 21,590 | SEC↗ |